These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1001851)

  • 1. Effects of monosodium glutamate administration in the neonatal period on the diabetic syndrome in KK mice.
    Cameron DP; Poon TK; Smith GC
    Diabetologia; 1976 Dec; 12(6):621-6. PubMed ID: 1001851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of monosodium glutamate-induced obesity in mice on carbohydrate metabolism in insulin secretion.
    Cameron DP; Cutbush L; Opat F
    Clin Exp Pharmacol Physiol; 1978; 5(1):41-51. PubMed ID: 639358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of oxygen consumption and locomotor activity in monosodium glutamate-induced obesity.
    Poon TK; Cameron DP
    Am J Physiol; 1978 May; 234(5):E532-4. PubMed ID: 645905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral and neurochemical effects of neonatal administration of monosodium L-glutamate in mice.
    Dawson R; Lorden JF
    J Comp Physiol Psychol; 1981 Feb; 95(1):71-84. PubMed ID: 7217414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose dependent development of diabetes mellitus and non-alcoholic steatohepatitis in monosodium glutamate-induced obese mice.
    Sasaki Y; Suzuki W; Shimada T; Iizuka S; Nakamura S; Nagata M; Fujimoto M; Tsuneyama K; Hokao R; Miyamoto K; Aburada M
    Life Sci; 2009 Sep; 85(13-14):490-8. PubMed ID: 19683013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monosodium L-glutamate lesions reduce susceptibility to hypoglycemic feeding and convulsions.
    Lorden JF; Sims JS
    Behav Brain Res; 1987 May; 24(2):139-46. PubMed ID: 3297094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of bezafibrate in nonalcoholic steatohepatitis model mice with monosodium glutamate-induced metabolic syndrome.
    Sasaki Y; Shimada T; Iizuka S; Suzuki W; Makihara H; Teraoka R; Tsuneyama K; Hokao R; Aburada M
    Eur J Pharmacol; 2011 Jul; 662(1-3):1-8. PubMed ID: 21549692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monosodium glutamate disruption of behavioral and endocrine function in the female rat.
    Rodriguez-Sierra JF; Sridaran R; Blake CA
    Neuroendocrinology; 1980 Sep; 31(3):228-35. PubMed ID: 7413022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of fasting on monosodium glutamate-obese rats.
    Ribeiro EB; Marmo MR; Andrade IS; Dolnikoff MS
    Braz J Med Biol Res; 1989; 22(7):917-21. PubMed ID: 2629958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pituitary responsiveness to LHRH stimulation in hamsters treated neonatally with monosodium glutamate.
    Lamperti AA; Baldwin DM
    Neuroendocrinology; 1982 Mar; 34(3):169-74. PubMed ID: 6803180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal monosodium glutamate treatment causes obesity, diabetes, and macrovesicular steatohepatitis with liver nodules in DIAR mice.
    Tsuneyama K; Nishida T; Baba H; Taira S; Fujimoto M; Nomoto K; Hayashi S; Miwa S; Nakajima T; Sutoh M; Oda E; Hokao R; Imura J
    J Gastroenterol Hepatol; 2014 Sep; 29(9):1736-43. PubMed ID: 24730643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased incidence of diabetes mellitus by monosodium glutamate in the non-obese diabetic (NOD) mouse.
    Nakajima H; Tochino Y; Fujino-Kurihara H; Yamada K; Gomi M; Tajima K; Kanaya T; Miyazaki A; Miyagawa J; Hanafusa T
    Res Commun Chem Pathol Pharmacol; 1985 Nov; 50(2):251-7. PubMed ID: 3909273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central but not peripheral glucoprivation is impaired in monosodium glutamate-treated rats.
    de Andrade IS; Gonzalez JC; Hirata AE; Carneiro G; Amado D; Cavalheiro EA; Dolnikoff MS
    Neurosci Lett; 2006 May; 398(1-2):6-11. PubMed ID: 16406310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monosodium glutamate: acute and chronic effects on rhythmic growth hormone and prolactin secretion, and somatostatin in the undisturbed male rat.
    Terry LC; Epelbaum J; Martin JB
    Brain Res; 1981 Jul; 217(1):129-42. PubMed ID: 6114783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of monosodium glutamate on the histogenesis of bone marrow in mice.
    Dhindsa KS; Omran RG; Bhup R
    Acta Anat (Basel); 1978; 101(3):212-7. PubMed ID: 654862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monosodium glutamate versus diet induced obesity in pregnant rats and their offspring.
    Afifi MM; Abbas AM
    Acta Physiol Hung; 2011 Jun; 98(2):177-88. PubMed ID: 21616776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of oral administration of monosodium glutamate (MSG) on the hypothalamic arcuate region of rat and mouse: a histological assay.
    Semprini ME; Conti L; Ciofi-Luzzatto A; Mariani A
    Biomedicine; 1974 Oct; 21(10):398-403. PubMed ID: 4616735
    [No Abstract]   [Full Text] [Related]  

  • 18. Reduced norepinephrine turnover in mice with monosodium glutamate-induced obesity.
    Yoshida T; Nishioka H; Nakamura Y; Kondo M
    Metabolism; 1984 Nov; 33(11):1060-3. PubMed ID: 6493048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-fostering reduces obesity induced by early exposure to monosodium glutamate in male rats.
    Miranda RA; da Silva Franco CC; de Oliveira JC; Barella LF; Tófolo LP; Ribeiro TA; Pavanello A; da Conceição EP; Torrezan R; Armitage J; Lisboa PC; de Moura EG; de Freitas Mathias PC; Vieira E
    Endocrine; 2017 Jan; 55(1):101-112. PubMed ID: 27116693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The distribution of enkephalin in the mediobasal hypothalamus of the mouse brain: effects of neonatal administration of MSG.
    Romagnano MA; Chafel TL; Pilcher WH; Joseph SA
    Brain Res; 1982 Mar; 236(2):497-504. PubMed ID: 7039767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.